Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
The inherited disorder is caused by genetic mutations that affects haemoglobin production
Read More
Tag: European Commission
Pfizer’s RSV vaccine receives EC approval to protect infants and older adults
The decision follows a recent recommendation from the European Medicines Agency’s human medicines committee
Read More
canSERV rolls out cancer research services across Europe
European wide research infrastructures, oncology experts and patient associations link up to combat cancer
Read More
Janssen’s teclistamab gets CMA from European Commission
Teclistamab is the first bispecific antibody worldwide to be approved for patients with relapsed and refractory multiple myeloma
Read More
European Commission approves Pfizer’s atopic dermatitis treatment
The approval from the European Commission (EC) is based on the results of five clinical studies, involving over 2,800 patients.
Read More
European Commission approves Nucala treatment in three diseases
This marks the first targeted treatment for eosinophilic granulomatosis with polyangiitis (EGPA)
Read More
EC approves Keytruda regimen for triple-negative breast cancer
Approval covers patients with locally recurrent or metastatic TNBC
Read More
EU nod for Bimzelx for moderate to severe plaque psoriasis
The approval is supported by three pivotal Phase III trials
Read More
AZ’s Forxiga gains EC, MHRA approvals for chronic kidney disease
Approval based on DAPA-CKD Phase III data
Read More
MSD, Bayer’s heart failure med Verquvo gains EU approval
Verquvo cleared for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction
Read More
EU approval for self-administered Crysvita
Crysvita is used to treat the rare genetic condition X-linked hypophosphataemia
Read More
EC clears AstraZeneca’s acquisition of Alexion
Clearance in the UK is still pending and remains a requirement to complete the proposed deal
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
